|
New Vitality™ hrGFP—new organism, new performance
Recombinant Renilla Reniformis GFP Displays Low Toxicity
Katie Felts • Brenda Rogers • Keith Chen • Henry Ji • Joe
Sorge • Peter Vaillancourt Stratagene
We have cloned and expressed the gene for the Renilla
reniformis green fluorescent protein, and have fully humanized the gene
using codons preferred in highly expressed human
genes.*,Y
High-level expression of functional fluorescent protein in retrovirally
transduced cells is substantially more consistent and less toxic over time
and passage number for this new humanized R. reniformis GFP (hrGFP)
than for the redshifted, humanized Aeqourea GFP (EGFP). Two
reporter vectors are now available with hrGFP downstream of an internal
ribosomal entry site (IRES) ±±,
allowing bicistronic expression of your gene of interest and hrGFP as well
as a third retroviral reporter vector.
Green fluorescent protein (GFP) has become a versatile tool for
monitoring mammalian expression and protein localization in the fields of
biochemistry, molecular and cell biology, high-throughput screening and
gene discovery.1,2 GFPs have been identified in a wide range of
coelenterates, and while recently the number of cloned GFPs has expanded,
to date the best characterized proteins are those from the jellyfish
Aequorea victoria and the anthazoan Renilla reniformis.
The purified native R. reniformis GFP is reported to have
certain characteristics that implicate it as a more attractive alternative
to the Aequorea protein for use as a biological marker3.
Renilla GFP absorbs light with a 5-fold higher extinction
coefficient than wild-type Aeqourea GFP, and 2.5-fold more
efficiently than red-shifted variants of the Aequorea protein.
Renilla GFP has a broader range of pH stability than
Aequorea GFP, and is more resistant to organic solvents, detergents
and proteases. In addition, Renilla GFP exists in solution as a
non-dissociable homodimer at all concentrations, so the exposed surface
area is less hydrophobic and less likely to interact with other proteins
in the cell. Aequorea GFP forms weak homodimers at moderate to low
concentrations, and is often cytotoxic. Due to this cytotoxicity,
researchers have often been frustrated in their attempts to produce stable
GFP-expressing cells lines using the Aequorea
protein4.
While the native R. reniformis protein has been well
characterized, cloning this gene has been difficult. We cloned the R.
reniformis gene and chemically synthesized a fully
humanized5 238 amino acid open reading frame for expression.
The humanized R. reniformis GFP (hrGFP) was cloned into the pFB
retroviral vector for expression analysis. Figure 1 shows the
results of transduction of a range of mammalian cell types with this
vector.

Fig.1
Spectral Analysis
The hrGFP gene was inserted into a mammalian expression vector and
expressed in CHO cells, and a spectral analysis was performed on crude CHO
cell extracts. The fluorescence profile for the cloned protein is
virtually identical to that reported for the native protein, with a single
major excitation peak at 500 nm (compared with 498 nm for the native
protein). The 500 nm peak is preceded by a vibrational shoulder at
approximately 470 nm, a characteristic of the native Renilla
GFP3. The emission spectra show a single peak at 506 nm for the
cloned protein, compared with the reported maximum of 509 nm for the
native protein (data not shown).
Low Toxicity

Fig.2
Production of stable GFP-expressing cell lines has been problematic for
many researchers due to toxicity of the Aequorea GFP4.
In order to compare the relative tolerance of cells for high-level
expression of the GFPs over time and passage number, we transduced HeLa
cells with retroviral vectors containing either the hrGFP gene, or that
for the red-shifted, humanized Aequorea protein (EGFP)2.
Cells were infected at an equivalent multiplicity of infection with one or
the other virus, and then passaged for several weeks in the absence of any
selection. At various times following infection, the transduced
populations were assayed for fluorescence intensity by FACS, and for
viability by visual inspection and fluorescence microscopy. As can be seen
in the Figure 2 and Figure 3, at 3
days post-infection, both hrGFP and EGFP show an equivalent, high level of
fluorescence. Following trypsinization for the first passage on day 4, we
observed a high degree of cell death for the EGFP expressing cells, and by
1 week post-infection, the EGFP-expressing population as a whole showed a
substantially diminished fluorescence intensity, while the hrGFP
population remained essentially as bright as on day 3. By two weeks
post-infection, over half of the EGFP-expressing population exhibited no
detectable fluorescence, with the remaining cells peaking at an intensity
that is greater than 15-fold below that for hrGFP, which again remained
unchanged.

Fig.3
Innovative Vectors
Three Vitality™ hrGFP reporter vectors are currently available for
mammalian expression: pIRES-hrGFP-1 and pIRES-hrGFP-2, and the pFB-hrGFP
retroviral vector.
The pIRES-hrGFP vectors contain an IRES between the multiple cloning
site (MCS) and hrGFP, allowing both your gene of interest and hrGFP
expression from the CMV promoter. The pIRES-hrGFP-1 vector also
contains a FLAG tag C-terminal to your gene of interest, and the
pIRES-hrGFP-2 vector contains an Hemagglutinin (HA) tag C-terminal to your
gene of interest. These vectors also contain a LoxP site
where either hygromycin, puromycin, or neomycin resistance cassettes can
be quickly inserted using site-specific recombination to provide your
choice of drug resistance markers (Figure 4). The pFB-hrGFP retroviral
vector is ideal for mammalian expression in difficult to transfect
cell lines.

Fig.4
Conclusion
The humanized R. reniformis green fluorescent protein displays a
level of fluoresence comparable to that for EGFP when expressed in a range
of mammalian cell types. When expressed at high levels in human cells, the
hrGFP is well tolerated over several passages, in contrast to EGFP, which
is generally cytotoxic after transduction of the EGFP gene. We have
carried a transduced population of HeLa cells for over 2 months in the
absence of selection, and have observed no significant loss of overall
fluorescence, and minimal cytopathic effect for the hrGFP-expressing
cells. On the other hand, substantial cell death for the EGFP-expressing
population resulted in a selection for cells exhibiting low fluoresence or
no detectable fluorescence.
REFERENCES
-
Chalfie, M. et. al. (1994). Science 263: 802-805.
-
Tsien, R.Y. (1998). Annu. Rev. Biochem. 67: 509-44.
-
Ward, W.W. et. al. (1980). Phytochem. and Phytobiol. 31:
611-615.
-
Hanazono et. al. (1997). Hum. Gene Ther. 8: 1313-1319.
-
Haas, J. et. al. (1996). Curr. Biol. 6(3): 315-324.
* Patent pending |
|